<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39313647</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1546-1696</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>23</Day></PubDate></JournalIssue><Title>Nature biotechnology</Title><ISOAbbreviation>Nat Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Chemical and topological design of multicapped mRNA and capped circular RNA to augment translation.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41587-024-02393-y</ELocationID><Abstract><AbstractText>Protein and vaccine therapies based on mRNA would benefit from an increase in translation capacity. Here, we report a method to augment translation named ligation-enabled mRNA-oligonucleotide assembly (LEGO). We systematically screen different chemotopological motifs and find that a branched mRNA cap effectively initiates translation on linear or circular mRNAs without internal ribosome entry sites. Two types of chemical modification, locked nucleic acid (LNA) N<sup>7</sup>-methylguanosine modifications on the cap and LNA + 5 × 2' O-methyl on the 5' untranslated region, enhance RNA-eukaryotic translation initiation factor (eIF4E-eIF4G) binding and RNA stability against decapping in vitro. Through multidimensional chemotopological engineering of dual-capped mRNA and capped circular RNA, we enhanced mRNA protein production by up to tenfold in vivo, resulting in 17-fold and 3.7-fold higher antibody production after prime and boost doses in a severe acute respiratory syndrome coronavirus 2 vaccine setting, respectively. The LEGO platform opens possibilities to design unnatural RNA structures and topologies beyond canonical linear and circular RNAs for both basic research and therapeutic applications.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Hongyu</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-9496-8586</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Dangliang</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-6598-8871</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Aditham</LastName><ForeName>Abhishek</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Jianting</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5691-5707</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jiahao</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6349-9799</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostas</LastName><ForeName>Franklin</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0939-1154</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maher</LastName><ForeName>Kamal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedrich</LastName><ForeName>Mirco J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McGovern Institute for Brain Research at MIT, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Science, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xavier</LastName><ForeName>Ramnik J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Computational and Integrative Biology, Department of Molecular Biology, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Feng</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-0178-7995</Identifier><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>McGovern Institute for Brain Research at MIT, Cambridge, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Brain and Cognitive Science, Massachusetts Institute of Technology, Cambridge, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-3090-9894</Identifier><AffiliationInfo><Affiliation>Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA. xwangx@mit.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Broad Institute of MIT and Harvard, Cambridge, MA, USA. xwangx@mit.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA. xwangx@mit.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1DP2GM146245</GrantID><Agency>U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)</Agency><Country /></Grant><Grant><GrantID>DK43351</GrantID><Agency>U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)</Agency><Country /></Grant><Grant><GrantID>DP2 GM146245</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DK135492</GrantID><Agency>U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)</Agency><Country /></Grant><Grant><GrantID>2R01HG009761-05</GrantID><Agency>U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Biotechnol</MedlineTA><NlmUniqueID>9604648</NlmUniqueID><ISSNLinking>1087-0156</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>24</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>23</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39313647</ArticleId><ArticleId IdType="doi">10.1038/s41587-024-02393-y</ArticleId><ArticleId IdType="pii">10.1038/s41587-024-02393-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mulligan, M. J. et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature 586, 589–593 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32785213</ArticleId><ArticleId IdType="doi">10.1038/s41586-020-2639-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Morais, P., Adachi, H. &amp; Yu, Y.-T. The critical contribution of pseudouridine to mRNA COVID-19 vaccines. Front. Cell Dev. Biol. 9, 789427 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34805188</ArticleId><ArticleId IdType="pmc">8600071</ArticleId><ArticleId IdType="doi">10.3389/fcell.2021.789427</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohner, E., Yang, R., Foo, K. S., Goedel, A. &amp; Chien, K. R. Unlocking the promise of mRNA therapeutics. Nat. Biotechnol. 40, 1586–1600 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36329321</ArticleId><ArticleId IdType="doi">10.1038/s41587-022-01491-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson, R. J., Hellen, C. U. T. &amp; Pestova, T. V. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 11, 113–127 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20094052</ArticleId><ArticleId IdType="pmc">4461372</ArticleId><ArticleId IdType="doi">10.1038/nrm2838</ArticleId></ArticleIdList></Reference><Reference><Citation>von der Haar, T., Gross, J. D., Wagner, G. &amp; McCarthy, J. E. G. The mRNA cap-binding protein eIF4E in post-transcriptional gene expression. Nat. Struct. Mol. Biol. 11, 503–511 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15164008</ArticleId><ArticleId IdType="doi">10.1038/nsmb779</ArticleId></ArticleIdList></Reference><Reference><Citation>Despic, V. &amp; Jaffrey, S. R. mRNA ageing shapes the Cap2 methylome in mammalian mRNA. Nature 614, 358–366 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36725932</ArticleId><ArticleId IdType="pmc">9891201</ArticleId><ArticleId IdType="doi">10.1038/s41586-022-05668-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Züst, R. et al. Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat. Immunol. 12, 137–143 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21217758</ArticleId><ArticleId IdType="pmc">3182538</ArticleId><ArticleId IdType="doi">10.1038/ni.1979</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanathan, A., Robb, G. B. &amp; Chan, S.-H. mRNA capping: biological functions and applications. Nucleic Acids Res. 44, 7511–7526 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27317694</ArticleId><ArticleId IdType="pmc">5027499</ArticleId><ArticleId IdType="doi">10.1093/nar/gkw551</ArticleId></ArticleIdList></Reference><Reference><Citation>Grudzien‐Nogalska, E. et al. Synthesis of anti‐reverse cap analogs (ARCAs) and their applications in mRNA translation and stability. Methods Enzymol. 431, 203–227 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17923237</ArticleId><ArticleId IdType="doi">10.1016/S0076-6879(07)31011-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepinski, J., Waddell, C., Stolarski, R., Darzynkiewicz, E. &amp; Rhoads, R. E. Synthesis and properties of mRNAs containing the novel ‘anti-reverse’ cap analogs 7-methyl(3′-O-methyl)GpppG and 7-methyl(3′-deoxy)GpppG. RNA 7, 1486–1495 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11680853</ArticleId><ArticleId IdType="pmc">1370192</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa, M., Murai, R., Hagiwara, H., Hoshino, T. &amp; Suyama, K. Preparation of eukaryotic mRNA having differently methylated adenosine at the 5′-terminus and the effect of the methyl group in translation. Nucleic Acids Symp. Ser. 53, 129–130 (2009).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nass/nrp065</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikorski, P. J. et al. The identity and methylation status of the first transcribed nucleotide in eukaryotic mRNA 5′ cap modulates protein expression in living cells. Nucleic Acids Res. 48, 1607–1626 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31984425</ArticleId><ArticleId IdType="pmc">7038993</ArticleId><ArticleId IdType="doi">10.1093/nar/gkaa032</ArticleId></ArticleIdList></Reference><Reference><Citation>Jurga, S. &amp; Barciszewski, J. (eds) Messenger RNA Therapeutics (Springer Nature, 2022).</Citation></Reference><Reference><Citation>Wesselhoeft, R. A., Kowalski, P. S. &amp; Anderson, D. G. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat. Commun. 9, 2629 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29980667</ArticleId><ArticleId IdType="pmc">6035260</ArticleId><ArticleId IdType="doi">10.1038/s41467-018-05096-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, R. et al. Engineering circular RNA for enhanced protein production. Nat. Biotechnol. 41, 262–272 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">35851375</ArticleId><ArticleId IdType="doi">10.1038/s41587-022-01393-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu, L. et al. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell 185, 1728–1744 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35460644</ArticleId><ArticleId IdType="pmc">8971115</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2022.03.044</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch, A., Aguilera, L., Morisaki, T., Munsky, B. &amp; Stasevich, T. J. Quantifying the dynamics of IRES and cap translation with single-molecule resolution in live cells. Nat. Struct. Mol. Biol. 27, 1095–1104 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32958947</ArticleId><ArticleId IdType="pmc">8351040</ArticleId><ArticleId IdType="doi">10.1038/s41594-020-0504-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe, N. et al. Complete chemical synthesis of minimal messenger RNA by efficient chemical capping reaction. ACS Chem. Biol. 17, 1308–1314 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35608277</ArticleId><ArticleId IdType="doi">10.1021/acschembio.1c00996</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawaguchi, D. et al. Phosphorothioate modification of mRNA accelerates the rate of translation initiation to provide more efficient protein synthesis. Angew. Chem. Int. Ed. Engl. 59, 17403–17407 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32627275</ArticleId><ArticleId IdType="doi">10.1002/anie.202007111</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojcik, R. et al. Novel N<sup>7</sup>-arylmethyl substituted dinucleotide mRNA 5′ cap analogs: synthesis and evaluation as modulators of translation. Pharmaceutics 13, 1941 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34834356</ArticleId><ArticleId IdType="pmc">8623273</ArticleId><ArticleId IdType="doi">10.3390/pharmaceutics13111941</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, X. et al. Structure-guided design, synthesis, and evaluation of guanine-derived inhibitors of the eIF4E mRNA–cap interaction. J. Med. Chem. 55, 3837–3851 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22458568</ArticleId><ArticleId IdType="doi">10.1021/jm300037x</ArticleId></ArticleIdList></Reference><Reference><Citation>Inagaki, M. et al. Cap analogs with a hydrophobic photocleavable tag enable facile purification of fully capped mRNA with various cap structures. Nat. Commun. 14, 2657 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37169757</ArticleId><ArticleId IdType="pmc">10175277</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-38244-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Kore, A. R., Shanmugasundaram, M., Charles, I., Vlassov, A. V. &amp; Barta, T. J. Locked nucleic acid (LNA)-modified dinucleotide mRNA cap analogue: synthesis, enzymatic incorporation, and utilization. J. Am. Chem. Soc. 131, 6364–6365 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19385620</ArticleId><ArticleId IdType="doi">10.1021/ja901655p</ArticleId></ArticleIdList></Reference><Reference><Citation>Senthilvelan, A. et al. Trinucleotide cap analogue bearing a locked nucleic acid moiety: synthesis, mRNA modification, and translation for therapeutic applications. Org. Lett. 23, 4133–4136 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34008991</ArticleId><ArticleId IdType="doi">10.1021/acs.orglett.1c01037</ArticleId></ArticleIdList></Reference><Reference><Citation>Aitken, C. E. &amp; Lorsch, J. R. A mechanistic overview of translation initiation in eukaryotes. Nat. Struct. Mol. Biol. 19, 568–576 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22664984</ArticleId><ArticleId IdType="doi">10.1038/nsmb.2303</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, Y., Mao, Y., Jia, L., Dong, L. &amp; Qian, S.-B. Bi-directional ribosome scanning controls the stringency of start codon selection. Nat. Commun. 12, 6604 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34782646</ArticleId><ArticleId IdType="pmc">8593136</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-26923-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Aditham, A. et al. Chemically modified mocRNAs for highly efficient protein expression in mammalian cells. ACS Chem. Biol. 17, 3352–3366 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34995053</ArticleId><ArticleId IdType="doi">10.1021/acschembio.1c00569</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellman, L. M. &amp; Fried, M. G. Electrophoretic mobility shift assay (EMSA) for detecting protein–nucleic acid interactions. Nat. Protoc. 2, 1849–1861 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17703195</ArticleId><ArticleId IdType="pmc">2757439</ArticleId><ArticleId IdType="doi">10.1038/nprot.2007.249</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagaraj, N. et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22068331</ArticleId><ArticleId IdType="pmc">3261714</ArticleId><ArticleId IdType="doi">10.1038/msb.2011.81</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell, S. F. et al. The 5′-7-methylguanosine cap on eukaryotic mRNAs serves both to stimulate canonical translation initiation and to block an alternative pathway. Mol. Cell 39, 950–962 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20864040</ArticleId><ArticleId IdType="pmc">2945613</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2010.08.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Balatsos, N. A. A., Maragozidis, P., Anastasakis, D. &amp; Stathopoulos, C. Modulation of poly(A)-specific ribonuclease (PARN): current knowledge and perspectives. Curr. Med. Chem. 19, 4838–4849 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22834816</ArticleId><ArticleId IdType="doi">10.2174/092986712803341539</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbracht, J. V. et al. CASC3 promotes transcriptome-wide activation of nonsense-mediated decay by the exon junction complex. Nucleic Acids Res. 48, 8626–8644 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32621609</ArticleId><ArticleId IdType="pmc">7470949</ArticleId><ArticleId IdType="doi">10.1093/nar/gkaa564</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, W., Sweet, T. J., Chamnongpol, S., Baker, K. E. &amp; Coller, J. Co-translational mRNA decay in Saccharomyces cerevisiae. Nature 461, 225–229 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19701183</ArticleId><ArticleId IdType="pmc">2745705</ArticleId><ArticleId IdType="doi">10.1038/nature08265</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dijk, E. et al. Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J. 21, 6915–6924 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12486012</ArticleId><ArticleId IdType="pmc">139098</ArticleId><ArticleId IdType="doi">10.1093/emboj/cdf678</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojtczak, B. A. et al. 5′-Phosphorothiolate dinucleotide cap analogues: reagents for messenger RNA modification and potent small-molecular inhibitors of decapping enzymes. J. Am. Chem. Soc. 140, 5987–5999 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29676910</ArticleId><ArticleId IdType="doi">10.1021/jacs.8b02597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohlen, J., Roiuk, M., Neff, M. &amp; Teleman, A. A. PRRC2 proteins impact translation initiation by promoting leaky scanning. Nucleic Acids Res. 51, 3391–3409 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36869665</ArticleId><ArticleId IdType="pmc">10123092</ArticleId><ArticleId IdType="doi">10.1093/nar/gkad135</ArticleId></ArticleIdList></Reference><Reference><Citation>Garshott, D. M. et al. iRQC, a surveillance pathway for 40S ribosomal quality control during mRNA translation initiation. Cell Rep. 36, 109642 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34469731</ArticleId><ArticleId IdType="pmc">8997904</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2021.109642</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowski, L. A., Hall, A. C. &amp; Mekhail, K. Ataxin-2: from RNA control to human health and disease. Genes 8, 157 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28587229</ArticleId><ArticleId IdType="pmc">5485521</ArticleId><ArticleId IdType="doi">10.3390/genes8060157</ArticleId></ArticleIdList></Reference><Reference><Citation>Hildebrandt, A. et al. The RNA-binding ubiquitin ligase MKRN1 functions in ribosome-associated quality control of poly(A) translation. Genome Biol. 20, 216 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31640799</ArticleId><ArticleId IdType="pmc">6805484</ArticleId><ArticleId IdType="doi">10.1186/s13059-019-1814-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Pattabhi, S., Knoll, M. L., Gale, M. Jr &amp; Loo, Y.-M. DHX15 is a coreceptor for RLR signaling that promotes antiviral defense against RNA virus infection. J. Interferon Cytokine Res. 39, 331–346 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31090472</ArticleId><ArticleId IdType="pmc">6590726</ArticleId><ArticleId IdType="doi">10.1089/jir.2018.0163</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing, J. et al. DHX15 is required to control RNA virus-induced intestinal inflammation. Cell Rep. 35, 109205 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34161762</ArticleId><ArticleId IdType="pmc">8276442</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2021.109205</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y. et al. Structural and functional insights into 5′-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nat. Struct. Mol. Biol. 17, 781–787 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20581823</ArticleId><ArticleId IdType="pmc">3744876</ArticleId><ArticleId IdType="doi">10.1038/nsmb.1863</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, X. et al. Three-dimensional intact-tissue sequencing of single-cell transcriptional states. Science 361, eaat5691 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29930089</ArticleId><ArticleId IdType="pmc">6339868</ArticleId><ArticleId IdType="doi">10.1126/science.aat5691</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng, H. et al. Spatially resolved single-cell translatomics at molecular resolution. Science 380, eadd3067 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37384709</ArticleId><ArticleId IdType="pmc">11146668</ArticleId><ArticleId IdType="doi">10.1126/science.add3067</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, H. et al. Branched chemically modified poly(A) tails enhance the translation capacity of mRNA. Nat. Biotechnol. https://doi.org/10.1038/s41587-024-02174-7 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-024-02174-7</ArticleId><ArticleId IdType="pubmed">39261590</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, A. S., Kranzusch, P. J., Doudna, J. A. &amp; Cate, J. H. D. eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation. Nature 536, 96–99 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27462815</ArticleId><ArticleId IdType="pmc">5003174</ArticleId><ArticleId IdType="doi">10.1038/nature18954</ArticleId></ArticleIdList></Reference><Reference><Citation>Moerke, N. J. et al. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell 128, 257–267 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17254965</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2006.11.046</ArticleId></ArticleIdList></Reference><Reference><Citation>Wesselhoeft, R. A. et al. RNA circularization diminishes immunogenicity and can extend translation duration in vivo. Mol. Cell 74, 508–520 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30902547</ArticleId><ArticleId IdType="pmc">6724735</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2019.02.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikó, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833–1840 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18797453</ArticleId><ArticleId IdType="doi">10.1038/mt.2008.200</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervantes, J. L., Weinerman, B., Basole, C. &amp; Salazar, J. C. TLR8: the forgotten relative revindicated. Cell. Mol. Immunol. 9, 434–438 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">23085951</ArticleId><ArticleId IdType="pmc">3498840</ArticleId><ArticleId IdType="doi">10.1038/cmi.2012.38</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehwinkel, J. &amp; Gack, M. U. RIG-I-like receptors: their regulation and roles in RNA sensing. Nat. Rev. Immunol. 20, 537–551 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32203325</ArticleId><ArticleId IdType="pmc">7094958</ArticleId><ArticleId IdType="doi">10.1038/s41577-020-0288-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Y. G. et al. N<sup>6</sup>-methyladenosine modification controls circular RNA immunity. Mol. Cell 76, 96–109 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31474572</ArticleId><ArticleId IdType="pmc">6778039</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2019.07.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, Y., Choe, J., Park, O. H. &amp; Kim, Y. K. Molecular mechanisms driving mRNA degradation by m<sup>6</sup>A modification. Trends Genet. 36, 177–188 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31964509</ArticleId><ArticleId IdType="doi">10.1016/j.tig.2019.12.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain, S. et al. Modulation of translational decoding by m<sup>6</sup>A modification of mRNA. Nat. Commun. 14, 4784 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37553384</ArticleId><ArticleId IdType="pmc">10409866</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-40422-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehret, F., Zhou, C. Y., Alexander, S. C., Zhang, D. &amp; Devaraj, N. K. Site-specific covalent conjugation of modified mRNA by tRNA guanine transglycosylase. Mol. Pharm. 15, 737–742 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28749687</ArticleId><ArticleId IdType="doi">10.1021/acs.molpharmaceut.7b00356</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer, K. D. et al. 5′ UTR m<sup>6</sup>A promotes cap-independent translation. Cell 163, 999–1010 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26593424</ArticleId><ArticleId IdType="pmc">4695625</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2015.10.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, P., Hellen, C. U. T. &amp; Pestova, T. V. Toward the mechanism of eIF4F-mediated ribosomal attachment to mammalian capped mRNAs. Genes Dev. 30, 1573–1588 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27401559</ArticleId><ArticleId IdType="pmc">4949329</ArticleId><ArticleId IdType="doi">10.1101/gad.282418.116</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellen, C. U. &amp; Sarnow, P. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev. 15, 1593–1612 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11445534</ArticleId><ArticleId IdType="doi">10.1101/gad.891101</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito Querido, J. et al. Structure of a human 48S translational initiation complex. Science 369, 1220–1227 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32883864</ArticleId><ArticleId IdType="doi">10.1126/science.aba4904</ArticleId></ArticleIdList></Reference><Reference><Citation>Querido, J. B. et al. The structure of a human translation initiation complex reveals two independent roles for the helicase eIF4A. Nat. Struct. Mol. Biol. 31, 455–464 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-023-01196-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozak, M. Adherence to the first-AUG rule when a second AUG codon follows closely upon the first. Proc. Natl Acad. Sci. USA 92, 2662–2666 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7708701</ArticleId><ArticleId IdType="pmc">42278</ArticleId><ArticleId IdType="doi">10.1073/pnas.92.7.2662</ArticleId></ArticleIdList></Reference><Reference><Citation>Eschbach, J. W., Kelly, M. R., Haley, N. R., Abels, R. I. &amp; Adamson, J. W. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N. Engl. J. Med. 321, 158–163 (1989).</Citation><ArticleIdList><ArticleId IdType="pubmed">2747747</ArticleId><ArticleId IdType="doi">10.1056/NEJM198907203210305</ArticleId></ArticleIdList></Reference><Reference><Citation>Karikó, K., Muramatsu, H., Keller, J. M. &amp; Weissman, D. Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin. Mol. Ther. 20, 948–953 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22334017</ArticleId><ArticleId IdType="pmc">3345990</ArticleId><ArticleId IdType="doi">10.1038/mt.2012.7</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang, D.-I. et al. The role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int. J. Mol. Sci. 22, 2719 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33800290</ArticleId><ArticleId IdType="pmc">7962638</ArticleId><ArticleId IdType="doi">10.3390/ijms22052719</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini, E. G., Testa, R. &amp; Savarino, V. Liver enzyme alteration: a guide for clinicians. CMAJ 172, 367–379 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15684121</ArticleId><ArticleId IdType="pmc">545762</ArticleId><ArticleId IdType="doi">10.1503/cmaj.1040752</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang, Q. et al. RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants. iScience 25, 104043 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35291264</ArticleId><ArticleId IdType="pmc">8915453</ArticleId><ArticleId IdType="doi">10.1016/j.isci.2022.104043</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel, A. B. et al. BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature 592, 283–289 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33524990</ArticleId><ArticleId IdType="doi">10.1038/s41586-021-03275-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher, K. et al. Mitigating autocorrelation during spatially resolved transcriptomics data analysis. Preprint at bioRxiv https://doi.org/10.1101/2023.06.30.547258 (2023).</Citation></Reference><Reference><Citation>Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing. Nat. Nanotechnol. 15, 313–320 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32251383</ArticleId><ArticleId IdType="pmc">7735425</ArticleId><ArticleId IdType="doi">10.1038/s41565-020-0669-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Riol-Blanco, L. et al. The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J. Immunol. 174, 4070–4080 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15778365</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.174.7.4070</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, A. M. et al. Cancer cell-intrinsic expression of MHC class II regulates the immune microenvironment and response to anti-PD-1 therapy in lung adenocarcinoma. J. Immunol. 204, 2295–2307 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32179637</ArticleId><ArticleId IdType="doi">10.4049/jimmunol.1900778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratky, W., Reis e Sousa, C., Oxenius, A. &amp; Spörri, R. Direct activation of antigen-presenting cells is required for CD8<sup>+</sup> T-cell priming and tumor vaccination. Proc. Natl Acad. Sci. USA 108, 17414–17419 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21987815</ArticleId><ArticleId IdType="pmc">3198339</ArticleId><ArticleId IdType="doi">10.1073/pnas.1108945108</ArticleId></ArticleIdList></Reference><Reference><Citation>Laczkó, D. et al. A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice. Immunity 53, 724–732 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32783919</ArticleId><ArticleId IdType="pmc">7392193</ArticleId><ArticleId IdType="doi">10.1016/j.immuni.2020.07.019</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabro, S. et al. Differential intrasplenic migration of dendritic cell subsets tailors adaptive immunity. Cell Rep. 16, 2472–2485 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27545885</ArticleId><ArticleId IdType="pmc">6323650</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2016.07.076</ArticleId></ArticleIdList></Reference><Reference><Citation>Dohnalkova, M. et al. Essential roles of RNA cap-proximal ribose methylation in mammalian embryonic development and fertility. Cell Rep. 42, 112786 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37436893</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2023.112786</ArticleId></ArticleIdList></Reference><Reference><Citation>Haussmann, I. U. et al. CMTr cap-adjacent 2′-O-ribose mRNA methyltransferases are required for reward learning and mRNA localization to synapses. Nat. Commun. 13, 1209 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35260552</ArticleId><ArticleId IdType="pmc">8904806</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-28549-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Someya, T., Ando, A., Kimoto, M. &amp; Hirao, I. Site-specific labeling of RNA by combining genetic alphabet expansion transcription and copper-free click chemistry. Nucleic Acids Res. 43, 6665–6676 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26130718</ArticleId><ArticleId IdType="pmc">4538826</ArticleId><ArticleId IdType="doi">10.1093/nar/gkv638</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellestor, F. &amp; Paulasova, P. The peptide nucleic acids (PNAs), powerful tools for molecular genetics and cytogenetics. Eur. J. Hum. Genet. 12, 694–700 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15213706</ArticleId><ArticleId IdType="doi">10.1038/sj.ejhg.5201226</ArticleId></ArticleIdList></Reference><Reference><Citation>Corey, D. R. &amp; Abrams, J. M. Morpholino antisense oligonucleotides: tools for investigating vertebrate development. Genome Biol. 2, reviews1015.1–reviews1015.3 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2001-2-5-reviews1015</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt, S. L. et al. Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs. Sci. Transl. Med. 11, eaat9143 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30700577</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.aat9143</ArticleId></ArticleIdList></Reference><Reference><Citation>Musunuru, K. et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429–434 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34012082</ArticleId><ArticleId IdType="doi">10.1038/s41586-021-03534-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Arevalo, C. P. et al. A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes. Science 378, 899–904 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36423275</ArticleId><ArticleId IdType="pmc">10790309</ArticleId><ArticleId IdType="doi">10.1126/science.abm0271</ArticleId></ArticleIdList></Reference><Reference><Citation>Foy, S. P. et al. Non-viral precision T cell receptor replacement for personalized cell therapy. Nature 615, 687–696 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36356599</ArticleId><ArticleId IdType="doi">10.1038/s41586-022-05531-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Granit, V. et al. Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study. Lancet Neurol. 22, 578–590 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37353278</ArticleId><ArticleId IdType="pmc">10416207</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(23)00194-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai, A. et al. Quantitative assessment of mRNA cap analogues as inhibitors of in vitro translation. Biochemistry 38, 8538–8547 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10387101</ArticleId><ArticleId IdType="doi">10.1021/bi9830213</ArticleId></ArticleIdList></Reference><Reference><Citation>Flamme, M., McKenzie, L. K., Sarac, I. &amp; Hollenstein, M. Chemical methods for the modification of RNA. Methods 161, 64–82 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30905751</ArticleId><ArticleId IdType="doi">10.1016/j.ymeth.2019.03.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X. et al. Structural insights into FTO’s catalytic mechanism for the demethylation of multiple RNA substrates. Proc. Natl Acad. Sci. USA 116, 2919–2924 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30718435</ArticleId><ArticleId IdType="pmc">6386707</ArticleId><ArticleId IdType="doi">10.1073/pnas.1820574116</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi, H. et al. Spatial atlas of the mouse central nervous system at molecular resolution. Nature 622, 552–561 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37758947</ArticleId><ArticleId IdType="pmc">10709140</ArticleId><ArticleId IdType="doi">10.1038/s41586-023-06569-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22743772</ArticleId><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigert, M., Schmidt, U., Haase, R., Sugawara, K. &amp; Myers, G. Star-convex polyhedra for 3D object detection and segmentation in microscopy. In Proceedings of the IEEE/CVF Winter Conference on Applications of Computer Vision (eds Ross, A., Cox, D. &amp; McCloskey, S.) 3666–3673 (IEEE, 2020).</Citation></Reference><Reference><Citation>Wolf, F. A., Angerer, P. &amp; Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29409532</ArticleId><ArticleId IdType="pmc">5802054</ArticleId><ArticleId IdType="doi">10.1186/s13059-017-1382-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, W. E., Li, C. &amp; Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118–127 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">16632515</ArticleId><ArticleId IdType="doi">10.1093/biostatistics/kxj037</ArticleId></ArticleIdList></Reference><Reference><Citation>Edupuganti, R. R. et al. N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) recruits and repels proteins to regulate mRNA homeostasis. Nat. Struct. Mol. Biol. 24, 870–878 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28869609</ArticleId><ArticleId IdType="pmc">5725193</ArticleId><ArticleId IdType="doi">10.1038/nsmb.3462</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander, S. C., Busby, K. N., Cole, C. M., Zhou, C. Y. &amp; Devaraj, N. K. Site-specific covalent labeling of RNA by enzymatic transglycosylation. J. Am. Chem. Soc. 137, 12756–12759 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26393285</ArticleId><ArticleId IdType="doi">10.1021/jacs.5b07286</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier, S., Güthe, S., Kiefhaber, T. &amp; Grzesiek, S. Foldon, the natural trimerization domain of T4 fibritin, dissociates into a monomeric A-state form containing a stable β-hairpin: atomic details of trimer dissociation and local β-hairpin stability from residual dipolar couplings. J. Mol. Biol. 344, 1051–1069 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15544812</ArticleId><ArticleId IdType="doi">10.1016/j.jmb.2004.09.079</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, H. et al. Raw SILAC mass spectrometry data of chemical and topological design of multi-capped mRNA and capped circular RNA. Zenodo https://doi.org/10.5281/zenodo.12611469 (2024).</Citation></Reference><Reference><Citation>Chen, H. et al. Lymph node STARmap/RIBOmap dataset of chemical and topological design of multi-capped mRNA and capped circular RNA. Zenodo https://doi.org/10.5281/zenodo.12518588 (2024).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>